MedPath

sing machine learning algorithms to assess response to treatment in rectal cancer

Not Applicable
Conditions
Health Condition 1: C20- Malignant neoplasm of rectum
Registration Number
CTRI/2021/02/031522
Lead Sponsor
Dr Akshay Baheti
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

i. Patients with rectal adenocarcinoma who underwent neoadjuvant treatment followed by surgery

ii. Availability of restaging high-resolution rectal MRI

iii. More than 75% of mucin on tumor on T2WI based on visual assessment

Exclusion Criteria

i. Recurrent rectal cancer

ii. Poor image quality (no high resolution T2WI)

iii. Final pathology not available from the institute

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Texture analysis of rectal tumors will be performed using a machine learning algorithm. These features will be used to build a predictive model to predict response being complete or not complete.Timepoint: The data will be analyzed in June 2022.
Secondary Outcome Measures
NameTimeMethod
ATimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath